Acute phase reactants in Alzheimer's disease

Biological Psychiatry

Volumn 39, Issue 12, 1996, Pages 1051-1052

  Lawlor, Brian A ^a   Swanwick, Gregory R J ^a   Feighery, Conleth ^a   Walsh, J Bernard ^a   Coakley, Davis ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Acute phase reactants; Alpha 1 antichymotrypsin; Alzheimer's disease; Immune reaction

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN;

ACUTE PHASE RESPONSE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029982359     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00426-2     Document Type: Article

References (12)

1. Abraham C (1992): The role of the acute phase protein alpha 1 antichymotrypsin in brain dysfunction and injury. Res Immunol 143:631-636.
2. Abraham CR, Selkoe DJ, Potter H (1988): Immunochemical identification of the serine protease inhibitor alpha 1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501.
3. Altstiel LD, Lawlor BA, Mohs RC, Schmeidler J, Dalbn A, Mehta P, Davis KL (1995): Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer disease patients. Dementia 6(1)17-20 1995.
4. Brugge K, Katzman R, Hill LR, Hansen LA, Saitoh T (1992): Serological alpha 1 antichymotrypsin in Down's syndrome and Alzheimer's disease. Ann Neurol 32:192-197.
5. Folstein MF, Folstein ME, McHugh PR (1975): Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198.
6. Hinds TR, Kukull WA, Van Belle G, Schellenberg GD, Villacres EC, Larson EB (1994): The relationship between serum alpha 1 antichymotrypsin and Alzheimer's disease. Neurobiol Aging 15:21-27.
7. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
8. Kuiper MA, Van Kamp GJ, Bergmans PLM, Schaltens P, Wolters EC (1993): Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. J Neural Transm 6:145-149.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurology 34:939-944.
10. Matsubara E, Amari M, Shoji M, et al (1988): Significance of measurement of serum alpha 1 antichymotrypsin in senile dementia of the Alzheimer type. J Clin Exp Med 145:907-908.
11. Matsubara E, Hirai S, Amari M, et al (1990): Alpha 1 antichymotrypsin as a possible biochemical marker for Alzheimer type dementia. Ann Neurol 28:561-567.
12. Rozemueller JM, Eikelboom P (1990): Acute phase proteins are present in amorphous plaques in the cerebral cortex but not in cerebellar cortex of patients with Alzheimer's disease. Neurosci Lett 1991;75-78.